Literature DB >> 2311153

Apnoea and unconsciousness after apparent recovery from alfentanil-supplemented anaesthesia.

R J Hudson1.   

Abstract

Several cases of recurrent respiratory depression progressing to apnoea and unconsciousness after apparent recovery from sufentanil have been reported recently. Alfentanil has the shortest elimination half-time of the narcotics used in anaesthesia, suggesting that it should be the least likely to cause postoperative respiratory depression. A case of recurrent unconsciousness and respiratory arrest after apparent recovery from alfentanil-isoflurane-nitrous oxide anaesthesia is reported. A total dose of 137 micrograms.kg-1 alfentanil was given over a 3.25-hr period to a 45-year-old female undergoing partial gastrectomy. Naloxone, 0.16 mg IV, rapidly restored spontaneous ventilation and consciousness. This case demonstrates that apnoea and unconsciousness can also recur after apparent recovery from alfentanil. Recovery room personnel should be aware of this phenomenon. Earlier detection may permit treatment before apnoea occurs. Patients given narcotic-supplemented anaesthesia should be monitored by capnography and/or pulse oximetry in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311153     DOI: 10.1007/BF03005480

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  15 in total

1.  Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery.

Authors:  M E Ausems; C C Hug; D R Stanski; A G Burm
Journal:  Anesthesiology       Date:  1986-10       Impact factor: 7.892

2.  Recurrent respiratory depression after alfentanil administration.

Authors:  R S Jaffe; D Coalson
Journal:  Anesthesiology       Date:  1989-01       Impact factor: 7.892

3.  Postoperative rigidity following sufentanil administration.

Authors:  M Goldberg; S Ishak; C Garcia; J McKenna
Journal:  Anesthesiology       Date:  1985-08       Impact factor: 7.892

4.  Plasma fentanyl concentrations and clinical observations during and after operation.

Authors:  H J McQuay; R A Moore; G M Paterson; A P Adams
Journal:  Br J Anaesth       Date:  1979-06       Impact factor: 9.166

5.  Respiratory arrest after recovery from anaesthesia supplemented with sufentanil.

Authors:  D Robinson
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

6.  Biphasic respiratory depression after fentanyldroperidol or fentanyl alone used to supplement nitrous oxide anesthesia.

Authors:  L D Becker; B A Paulson; R D Miller; J W Severinghaus; E I Eger
Journal:  Anesthesiology       Date:  1976-04       Impact factor: 7.892

7.  Pronounced, episodic oxygen desaturation in the postoperative period: its association with ventilatory pattern and analgesic regimen.

Authors:  D M Catley; C Thornton; C Jordan; J R Lehane; D Royston; J G Jones
Journal:  Anesthesiology       Date:  1985-07       Impact factor: 7.892

8.  Tissue redistribution of fentanyl and termination of its effects in rats.

Authors:  C C Hug; M R Murphy
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

9.  Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.

Authors:  R J Hudson; I R Thomson; J E Cannon; R M Friesen; R C Meatherall
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

10.  Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery.

Authors:  R J Hudson; R G Bergstrom; I R Thomson; M A Sabourin; M Rosenbloom; L Strunin
Journal:  Anesthesiology       Date:  1989-03       Impact factor: 7.892

View more
  1 in total

1.  Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.

Authors:  R J Hudson; I R Thomson; P M Burgess; M Rosenbloom
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.